|

Rescue medications for chemotherapy Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 3: 1

Top Sponsors

  • Merck Sharp & Dohme LLC1

Indications

  • Bladder Cancer1
  • Cancer1

Cincinnati, Ohio1 trial

A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)

TriHealth Cancer Institute-Good Samaritan Hospital ( Site 0822)

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.